Proof of the involvement of platelet activating factor (Paf-acether) in pulmonary complex immune systems using a specific Paf-acether receptor antagonist: BN 52021
- 31 December 1986
- journal article
- Published by Elsevier in Progress in Lipid Research
- Vol. 25, 277-288
- https://doi.org/10.1016/0163-7827(86)90057-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L.Blood & Vessel, 1985
- The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregationInflammation Research, 1984
- THE PLATELET IN ASTHMAThe Lancet, 1984
- Platelet‐activating factor: a possible mediator of the dual response to allergen?Clinical and Experimental Allergy, 1984
- Specific receptor sites for 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranesBiochemistry, 1983
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)Annals of the New York Academy of Sciences, 1981
- The action of leukotriene B4 (LTB4) on the lungProstaglandins and Medicine, 1980
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972
- Versuchsanordnung zu Untersuchungen an der BronchiàlmuskulaturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1940